Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1994-07-25
1997-04-08
Scheiner, Toni R.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303879, 435331, 4353391, 4241481, C07K 1608, C07K 1610, C12P 2108
Patent
active
056189222
ABSTRACT:
The present invention provides a monoclonal antibody, designated NM03, which specifically binds HIV-1 gp 120.
REFERENCES:
patent: 5019387 (1991-05-01), Haynes et al.
Akerblom et al., "Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120", AIDS, 4:953-960 (1990).
Albovini et al., Eds., "Detection of HIV in Clinical Specimens", pp. 15-29 in Techniques in HIV Research, Stockton Press, New York, New York (1990).
Durda et al., "HIV-1 Neutralizing Monoclonal Antibodies Induced by a Synthetic Peptide", AIDS Research and Human Retroviruses, 6:1115-1123 (1990).
Emini et al., "Prevention of HIV-1 Infection in Chimpanzees by gp120 V3 Domain-Specific Monoclonal Antibody", Nature, 335:728-730 (1992).
Godding, "Antibody Production by Hybridomas", J. Immunol. Meth., 39:285-308 (1980).
Goudsmit et al., "Human Immunodeficiency Virus Type 1 Neutralization Epitome With Conserved Architecture Elicits Early Type-Specific Antibodies in Experimentally Infected Chimpanzees", Proc. Natl. Acad. Sci. USA, 85:4478-4482 (1988).
Haigwood et al., "Evidence for Neutralizing Antibodies Directed Against Conformational Epitopes of HIV-1 gp120", Vaccines, 90:313-320 (1990).
Ho et al., "Conformational Epitope on gp120 Important in CD4 Binding and Human Immunodeficiency Virus Type 1 Neutralization Identified by a Human Monoclonal Antibody", J. Virol., 65(1);489-493 (1991).
Ho et al., "Second Conserved Domain of gp120 Is Important for HIV Infectivity and Antibody Neutralization", Science, 239:1021-1023 (1988).
Holley et al., "Prediction of Optimal Peptide Mixtures to Induce Broadly Neutralizing Antibodies to Human Immunodeficiency Virus Type 1", Proc. Natl. Acad. Sci. USA, 85:6800-6804 (1991).
Jackson et al., "Passive Immunoneutralisation of Human Immunodeficiency Virus in Patients with Advanced AIDS", Lancet, 2:647-652 (1988).
Javaherian et al., "Broadly Neutralizing Antibodies Elicited by the Hypervariable Neutralizing Determinant of HIV-1", Science, 250: 1590-1593 (1990).
Javaherian et al., "Principal Neutralizing Domain of the Human Immunodeficiency Virus Type I Envelope Protein", Proc. Natl. Acad. Sci. USA, 86:6768-6772 (1989).
Karpas et al., "Effects of Passive Immunization in Patients with the Acquired Immunodeficiency Syndrome-Related Complex and Acquired Immunodeficiency Syndrome", Proc. Natl. Acad. Sci. USA, 85:9234-9237 (1988).
LaRosa et al., "Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing Determinant", Science, 249:932-935 (1990).
Lasky et al., "Neutralization of the AIDS Retrovirus by Antibodies to a Recombinant Envelope Glycoprotein", Science, 233: 209-212 (1986).
Liou et al., "A Chimeric Mouse-Human Antibody that Retains Specificity for HIV gp120 and Mediates the Lysis of HIV-Infected Cells", J. Immunol., 143(12):3967-3975 (1989).
Matsushita et al., "Characterization of a Human Immunodeficiency Virus Neutralizing Monoclonal Antibody and Mapping of the Neutralizing Epitope", J. Virol., 62:2107-2114 (1988).
McCune, "HIV-1: The Infective Process in Vivo", Cell, 645:351-363 (1991).
Ohno et al., "A broadly neutralizing monoclonal antibody that recognizes the V.sub.3 region of human immunodeficiency virus type 1 glycoprotein gp120", Proc. Natl. Acad. Sci. USA, 88:10726-10729 (1991).
Oi and Herzenberg, "Immunoglobulin-Producing Hybrid Cell Lines", Selected Methods Cell Immunology: 351-372 (1979).
Palker et al., "Type-specific Neutralization of the Human Immunodeficiency Virus with Antibodies to Env-encoded Synthetic Peptides", Proc. Natl. Acad. Sci. USA, 85:1932-1936 (1988).
Putney et al., "HTLV-III/LAV-Neutralizing Antibodies to an E. Coli-Produced Fragment of the Virus Envelope", Science, 234:1392-1395 (1986).
Rusche et al., "Antibodies That Inhibit Fusion of Human Immunodeficiency Virus-Infected Cells Bind a 24-Amino Acid Sequence of the Viral Envelope", Proc. Natl. Acad. Sci. USA, 85:3198-3202 (1988).
Scott et al., "Human Monoclonal Antibody That Recognizes the V3 Region of Human Immunodeficiency Virus gp120 and Neutralizes the Human T-Lymphoctropic", Proc. Natl. Acad. Sci. USA, 87:8597-8601 (1990).
Weiss et al., "Variable and Conserved Neutralization Antigens of Human Immunodeficiency Virus", Nature, 324:572-575 (1986).
Cohen Science vol. 264. 20 May 1994 p. 1072.
Fahey et al. Clin Exp. Immunol. 1992 88 1-5.
Ohno Tsuneya
Terada Masaki
Yoneda Yukio
Nissin Shokuhin Kabushiki Kaisha
Scheiner Toni R.
LandOfFree
NM03 antibody materials and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NM03 antibody materials and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NM03 antibody materials and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2398553